BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Staging
995 results:

  • 1. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
    Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
    [No Abstract]    [Full Text] [Related]  

  • 2. Defining distal splenopancreatectomy by the mesopancreas.
    Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
    Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
    Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
    BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
    Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predicting the unpredictable: a robust nomogram for predicting recurrence in patients with ampullary carcinoma.
    Chen R; Zhu L; Zhang Y; Cui D; Chen R; Guo H; Peng L; Xiao C
    BMC Cancer; 2024 Feb; 24(1):212. PubMed ID: 38360582
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Artificial intelligence to predict T4 stage of pancreatic ductal adenocarcinoma using CT imaging.
    Miao Q; Wang X; Cui J; Zheng H; Xie Y; Zhu K; Chai R; Jiang Y; Feng D; Zhang X; Shi F; Tan X; Fan G; Liang K
    Comput Biol Med; 2024 Mar; 171():108125. PubMed ID: 38340439
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
    Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
    Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Improved Clinical staging System for Localized pancreatic cancer Using the ABC Factors: A TAPS Consortium Study.
    Dekker EN; van Dam JL; Janssen QP; Besselink MG; DeSilva A; Doppenberg D; van Eijck CHJ; Nasar N; O'Reilly EM; Paniccia A; Prakash LR; Tzeng CD; Verkolf EMM; Wei AC; Zureikat AH; Katz MHG; Groot Koerkamp B;
    J Clin Oncol; 2024 Apr; 42(12):1357-1367. PubMed ID: 38315954
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Treatment Experience of Chemotherapy and Carbon-Ion Radiotherapy followed by Curative Conversion Surgery for Initially Locally Advanced Unresectable pancreatic cancer after Distal Gastrectomy].
    Watanabe H; Sugawara S; Takahashi R; Ashitomi Y; Kawashiro S; Sato H; Nemoto K; Kono M; Futakuchi M; Motoi F
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1959-1961. PubMed ID: 38303264
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Trends and disparities in access to minimally invasive distal pancreatectomy (midp): an eight-year analysis from the national cancer database.
    Jehan FS; Khreiss M; Seth A; Aziz H
    J Robot Surg; 2024 Jan; 18(1):52. PubMed ID: 38280048
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.
    Wang Y; Sun X; Chen C; Ge H; Sun J; Li E; Cai Z; Fu Q; Sun X; Wu J; Ye M; Cao W; Chen Q; Wei X; Han X; Sun K; Yan Q; Huang W; Wu L; Zeng Y; Zhang Q; Liang T
    Cancer Lett; 2024 Mar; 585():216654. PubMed ID: 38272344
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
    Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
    Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
    [TBL] [Abstract] [Full Text] [Related]  

  • 13.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected pancreatic cancer.
    Murthy P; Zenati MS; AlMasri SS; DeSilva A; Singhi AD; Paniccia A; Lee KK; Simmons RL; Bahary N; Lotze MT; Zureikat AH
    J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237070. PubMed ID: 38150819
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
    Beck J; Siebenhüner A; Wild D; Christ E; Refardt J
    Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38117915
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inadequacy of the eighth edition of the American Joint Committee on cancer pancreatic cancer staging system for invasive carcinoma associated with premalignant lesions in the pancreas: an analysis using the National cancer Database.
    Jung HS; Lee M; Han Y; Thomas AS; Yun WG; Cho YJ; Kluger MD; Jang JY; Kwon W
    HPB (Oxford); 2024 Mar; 26(3):400-409. PubMed ID: 38114399
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery.
    Li B; Yin X; Ding X; Zhang G; Jiang H; Chen C; Guo S; Jin G
    BMC Surg; 2023 Dec; 23(1):370. PubMed ID: 38066512
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.
    Shi W; Wartmann T; Accuffi S; Al-Madhi S; Perrakis A; Kahlert C; Link A; Venerito M; Keitel-Anselmino V; Bruns C; Croner RS; Zhao Y; Kahlert UD
    Br J Cancer; 2024 Jan; 130(1):125-134. PubMed ID: 37950093
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy of staging Laparoscopy in Patients With pancreatic cancer: A Single Center Prospective Cohort Study.
    Shindo Y; Tokumitsu Y; Matsui H; Nakajima M; Kimura Y; Iida M; Suzuki N; Takeda S; Ioka T; Nagano H
    In Vivo; 2023; 37(6):2704-2709. PubMed ID: 37905607
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 50.